Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 CAD | -0.38% | -0.75% | +3.11% |
Business Summary
Number of employees: 12
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 7 | 100.0 % | 6 | 100.0 % | -17.32% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
96.0
%
| 7 | 95.7 % | 6 | 96.0 % | -17.04% |
Ireland
2.7
%
| 0 | 1.5 % | 0 | 2.7 % | +54.25% |
Other
1.1
%
| 0 | 0.1 % | 0 | 1.1 % | +1,558.79% |
Denmark
0.2
%
| 0 | 2.8 % | 0 | 0.2 % | -92.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 03/10/19 | |
Director of Finance/CFO | - | 23/01/22 | |
Patricia Zahn
ADM | Chief Administrative Officer | - | 30/09/15 |
Nicola Ammer
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/14 |
Michael Teifel
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/03 |
Matthias Gerlach
PRN | Corporate Officer/Principal | - | 31/12/00 |
Eckhard Guenther
PRN | Corporate Officer/Principal | - | 31/12/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
BRD | Director/Board Member | 70 | 31/12/19 |
Peter Edwards
BRD | Director/Board Member | 62 | 14/05/20 |
Dennis Turpin
BRD | Director/Board Member | - | 04/05/21 |
Carolyn Egbert
CHM | Chairman | - | 31/07/12 |
Chief Executive Officer | 60 | 03/10/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,855,876 | 4,664,308 ( 96.05 %) | 0 | 96.05 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+3.11% | 9.4M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AEZS Stock
- Company Aeterna Zentaris Inc.